Meeting
2014 ASCO Annual Meeting
A phase I study of the single-agent CDK4/6 inhibitor LEE011 in pts with advanced solid tumors and lymphomas.
Authors
Jeffrey R. Infante
Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
Jeffrey R. Infante , Geoffrey Shapiro , Petronella Witteveen , John F. Gerecitano , Vincent Ribrag , Rashmi Chugh , Isra Issa , Abhijit Chakraborty , Alessandro Matano , Xumei Zhao , Sudha Parasuraman , Phillipe Cassier
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Developmental Therapeutics: Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics
Sub Track
Cell Cycle and Checkpoints
Clinical Trial Registration Number
NCT01237236
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 2528^)
DOI
10.1200/jco.2014.32.15_suppl.2528
Abstract #
2528^
Poster Bd #
43
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
A phase I study of the CDK4/6 inhibitor, palbociclib plus 5-fluorouracil (5FU) in patients with advanced solid tumor malignancies (NCT01522989).
First Author: Michael J. Pishvaian
Poster
2024 ASCO Annual Meeting
TACTIVE-K: Phase 1b/2 study of vepdegestrant, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, in combination with PF-07220060, a cyclin-dependent kinase (CDK)4 inhibitor, in ER+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer.
First Author: Melinda L. Telli
Poster
2023 ASCO Annual Meeting
BLU-222, an oral, potent, and selective CDK2 inhibitor, in patients with advanced solid tumors: Phase 1 monotherapy dose escalation.
First Author: Manish R. Patel
Poster
2020 ASCO Virtual Scientific Program
First-in-human phase I study of SY-5609, an oral, potent, and selective noncovalent CDK7 inhibitor, in adult patients with select advanced solid tumors.
First Author: Kyriakos P. Papadopoulos